mdlinx mdlinx
Physician Assistant Articles on MDLinx

Higher vs. lower fluid volume for septic shock: clinical characteristics and outcome in unselected patients in a prospective, multicenter cohort Critical Care, 05/09/2012

Smith SH et al. – In this cohort of unselected ICU patients with septic shock, initial fluid volume was not associated with mortality. In patients with shock for three days or more, higher fluid volumes including crystalloids, colloids and blood products were associated with reduced mortality.

Methods
  • The authors conducted a prospective, multicenter, observational study of all adult patients with septic shock during a 3-month study period at six general ICUs; three in university hospitals and three in regional hospitals.
  • After day 1 and 3 of shock, patients were divided into two groups according to the overall median fluid volumes.
  • Characteristics between these groups were compared using non-parametric and Chi-square statistics.

Results
  • The 164 included patients received median 4.0 l (IQR 2.3-6.3) of fluid during the first day of septic shock.
  • Patients receiving higher volumes (>4.0 l) on day 1 had higher p-lactate (3.4 (2.2-5.5) vs. 2.0 (1.6-3.0)mmol l-1, P<0.0001) compared to those receiving lower volumes.
  • In contrast simplified acute physiology score (SAPS) II (54 (45-64) vs. 54 (45-67), p=0.73), sequential organ failure assessment (SOFA) score (11 (9-13) vs. 11 (9-13), P=0.78) and 90-day mortality (48 vs. 53%, P=0.27) did not differ between groups.
  • The 95 patients who still had shock on day 3 had received 7.5 l (4.3-10.8) of fluid by the end of day 3.
  • Patients receiving higher volumes (>7.5 l) had higher p-lactate (2.6 (1.7-3.4) vs. 1.9 (1.6-2.4)mmol l-1, P<0.01) on day 3 and lower 90-day mortality (40 vs. 62%, P = 0.03) than those receiving lower volumes in spite of comparable admission SAPS II (53 (46-67) vs. 55 (49-62), P=0.47) and SOFA scores on day 3 (10 (8-13) vs. 11 (10-14), P=0.33).

Read this article on Critical Care



Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close